AstraZeneca Respiratory Head: Tezepelumab Could Be 'Game Changer'

 
• By Sten Stovall
  
Asthama
Tezepelumab Likely To Enter Phase III Testing In Severe Asthma Late In 2017 Or Early 2018 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D